Modifying the mechanics of healing infarcts: Is better the enemy of good?

Journal of Molecular and Cellular Cardiology

Volumn 93, Issue , 2016, Pages 115-124

  Clarke, Samantha A ^a   Richardson, William J ^a,c   Holmes, Jeffrey W ^a,b,c  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Biomechanics; Computational modeling; Extracellular matrix; Heart; Myocardial infarction

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE;

EX VIVO STUDY; EXTRACELLULAR MATRIX; GEOMETRY; HEALING INFARCT; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART INFARCT RUPTURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICULAR PUMP DEPRESSION; HEART STRESS; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN STRUCTURE; REVIEW; TISSUE REGENERATION; ANIMAL; DISEASE COURSE; HEART VENTRICLE; HEART VENTRICLE REMODELING; INFLAMMATION; MECHANICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; WOUND HEALING;

ANIMALS; COLLAGEN; DISEASE PROGRESSION; HEART FAILURE; HEART VENTRICLES; HUMANS; INFLAMMATION; MECHANICAL PHENOMENA; MYOCARDIAL INFARCTION; VENTRICULAR REMODELING; WOUND HEALING;

EID: 84949683193     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.028     Document Type: Review

References (96)

1. Tennant R., Wiggers C.J. The effect of coronary occlusion on myocardial contraction. Am. J. Physiol. 1935, 112:351-361.
2. Connelly C., Vogel W.M., Hernandez Y.M., Apstein C.S. Movement of necrotic wavefront after coronary artery occlusion in rabbit. Am. J. Physiol. 1982, 243:H682-H690.
3. Fomovsky G.M., Holmes J.W. Evolution of scar structure, mechanics, and ventricular function after myocardial infarction in the rat. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H221-H228. 10.1152/ajpheart.00495.2009.
4. Holmes J.W., Nuñez J.A., Covell J.W. Functional implications of myocardial scar structure. Am. J. Physiol. 1997, 272:H2123-H2130.
5. Clarke S.A., Goodman N.C., Ailawadi G., Holmes J.W. Effect of scar compaction on the therapeutic efficacy of anisotropic reinforcement following myocardial infarction in the dog. J. Cardiovasc. Transl. Res. 2015, 8:353-361. 10.1007/s12265-015-9637-1.
6. McCormick R.J., Musch T.I., Bergman B.C., Thomas D.P. Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. Am. J. Physiol. 1994, 266:H354-H359.
7. Jugdutt B.I., Amy R.W.M. Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J. Am. Coll. Cardiol. 1986, 7:91-102. 10.1016/S0735-1097(86)80265-0.
8. Gupta K.B., Ratcliffe M.B., Fallert M.A., Edmunds L.H., Bogen D.K. Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation. Circulation 1994, 89:2315-2326. 10.1161/01.CIR.89.5.2315.
9. Vivaldi M.T., Eyre D.R., Kloner R.A., Schoen F.J. Effects of methylprednisolone on collagen biosynthesis in healing acute myocardial infarction. Am. J. Cardiol. 1987, 60:424-425. 10.1016/0002-9149(87)90277-3.
10. Zimmerman S.D., Thomas D.P., Velleman S.G., Li X., Hansen T.R., McCormick R.J. Time course of collagen and decorin changes in rat cardiac and skeletal muscle post-MI. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H1816-H1822.
11. Fomovsky G.M., Rouillard A.D., Holmes J.W. Regional mechanics determine collagen fiber structure in healing myocardial infarcts. J. Mol. Cell. Cardiol. 2012, 52:1083-1090. 10.1016/j.yjmcc.2012.02.012.
12. Whittaker P., Boughner D.R., Kloner R.A. Analysis of healing after myocardial infarction using polarized light microscopy. Am. J. Pathol. 1989, 134:879-893.
13. Horn M.A., Trafford A.W. Aging and the cardiac collagen matrix: novel mediators of fibrotic remodelling. J. Mol. Cell. Cardiol. 2016, 93:175-185.
14. Tyberg J.V., Forrester J.S., Wyatt H.L., Goldner S.J., Parmley W.W., Swan H.J. An analysis of segmental ischemic dysfunction utilizing the pressure-length loop. Circulation 1974, 49:748-754. 10.1161/01.CIR.49.4.748.
15. Theroux P., Ross J., Franklin D., Covell J.W., Bloor C.M., Sasayama S. Regional myocardial function and dimensions early and late after myocardial infarction in the unanesthetized dog. Circ. Res. 1977, 40:158-165. 10.1161/01.RES.40.2.158.
16. Richardson W.J., Clarke S.A., Holmes J.W. Physiological implications of myocardial scar structure. Compr. Physiol. 2015, 5:1877-1909. 10.1002/cphy.c140067.
17. Holmes J.W., Yamashita H., Waldman L.K., Covell J.W. Scar remodeling and transmural deformation after infarction in the pig. Circulation 1994, 90:411-420.
18. Bogaert J., Maes A., Van de Werf F., Bosmans H., Herregods M.C., Nuyts J., et al. Functional recovery of subepicardial myocardial tissue in transmural myocardial infarction after successful reperfusion: an important contribution to the improvement of regional and global left ventricular function. Circulation 1999, 99:36-43.
19. Kidambi A., Mather A.N., Swoboda P., Motwani M., Fairbairn T.A., Greenwood J.P., et al. Relationship between myocardial edema and regional myocardial function after reperfused acute myocardial infarction: an MR imaging study. Radiology 2013, 267:701-708. 10.1148/radiol.12121516.
20. Kramer C.M., Rogers W.J., Theobald T.M., Power T.P., Geskin G., Reichek N. Dissociation between changes in intramyocardial function and left ventricular volumes in the eight weeks after first anterior myocardial infarction. J. Am. Coll. Cardiol. 1997, 30:1625-1632.
21. Parmley W.W., Chuck L., Kivowitz C., Matloff J.M., Swan H.J. In vitro length-tension relations of human ventricular aneurysms. Relation of stiffness to mechanical disadvantage. Am. J. Cardiol. 1973, 32:889-894. 10.1016/S0002-9149(73)80153-5.
22. Connelly C.M., Vogel W.M., Wiegner A.W., Osmers E.L., Bing O.H., Kloner R.A., et al. Effects of reperfusion after coronary artery occlusion on post-infarction scar tissue. Circ. Res. 1985, 57:562-577. 10.1161/01.RES.57.4.562.
23. Przyklenk K., Connelly C.M., McLaughlin R.J., Kloner R.A., Apstein C.S. Effect of myocyte necrosis on strength, strain, and stiffness of isolated myocardial strips. Am. Heart J. 1987, 114:1349-1359. 10.1016/0002-8703(87)90536-9.
24. Holmes J.W., Borg T.K., Covell J.W. Structure and mechanics of healing myocardial infarcts. Annu. Rev. Biomed. Eng. 2005, 7:223-253. 10.1146/annurev.bioeng.7.060804.100453.
25. Omens J.H., Miller T.R., Covell J.W. Relationship between passive tissue strain and collagen uncoiling during healing of infarcted myocardium. Cardiovasc. Res. 1997, 33:351-358.
26. Fujimoto K.L., Tobita K., Merryman W.D., Guan J., Momoi N., Stolz D.B., et al. An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J. Am. Coll. Cardiol. 2007, 49:2292-2300. 10.1016/j.jacc.2007.02.050.
27. McGarvey J.R., Mojsejenko D., Dorsey S.M., Nikou A., Burdick J.A., Gorman J.H., et al. Temporal changes in infarct material properties: an in vivo assessment using magnetic resonance imaging and finite element simulations. Ann. Thorac. Surg. 2015, 100:582-589. 10.1016/j.athoracsur.2015.03.015.
28. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172. 10.1161/01.CIR.81.4.1161.
29. Sato S., Ashraf M., Millard R.W., Fujiwara H., Schwartz A. Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J. Mol. Cell. Cardiol. 1983, 15:261-275.
30. Takahashi S., Barry A., Factor S. Collagen degradation in ischaemic rat hearts. Biochem. J. 1990, 265:233-241.
31. Gao X.-M., White D.A., Dart A.M., Du X.-J. Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions. Pharmacol. Ther. 2012, 134:156-179. 10.1016/j.pharmthera.2011.12.010.
32. van den Borne S.W.M., van de Schans V.A.M., Strzelecka A.E., Vervoort-Peters H.T.M., Lijnen P.M., Cleutjens J.P.M., et al. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc. Res. 2009, 84:273-282. 10.1093/cvr/cvp207.
33. Gao X.M., Xu Q., Kiriazis H., Dart A.M., Du X.J. Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc. Res. 2005, 65:469-477. 10.1016/j.cardiores.2004.10.014.
34. Gao X.M., Ming Z., Su Y., Fang L., Kiriazis H., Xu Q., et al. Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int. J. Cardiol. 2010, 143:20-28. 10.1016/j.ijcard.2009.01.019.
35. Sun M., Dawood F., Wen W.H., Chen M., Dixon I., Kirshenbaum L.A., et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 2004, 110:3221-3228. 10.1161/01.CIR.0000147233.10318.23.
36. Hayashidani S., Tsutsui H., Ikeuchi M., Shiomi T., Matsusaka H., Kubota T., et al. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1229-H1235. 10.1152/ajpheart.00207.2003.
37. Heymans S., Luttun A., Nuyens D., Theilmeier G., Creemers E., Moons L., et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 1999, 5:1135-1142. 10.1038/13459.
38. Ma Y., Halade G.V., Zhang J., Ramirez T.A., Levin D., Voorhees A.A., et al. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ. Res. 2013, 112:675-688. 10.1161/CIRCRESAHA.111.300502.
39. Fang L., Gao X.-M., Samuel C.S., Su Y., Lim Y.L., Dart A.M., et al. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction. Clin. Sci. (Lond.) 2008, 115:99-106. 10.1042/CS20070365.
40. Connelly C.M., Ngoy S., Schoen F.J., Apstein C.S. Biomechanical properties of reperfused transmural myocardial infarcts in rabbits during the first week after infarction. Implications for left ventricular rupture. Circ. Res. 1992, 71:401-413. 10.1161/01.RES.71.2.401.
41. Sunagawa K., Maughan W.L., Sagawa K. Effect of regional ischemia on the left ventricular end-systolic pressure-volume relationship of isolated canine hearts. Circ. Res. 1983, 52:170-178. 10.1161/01.RES.52.2.170.
42. Bogen D.K., Rabinowitz S.A., Needleman A., McMahon T.A., Abelmann W.H. An analysis of the mechanical disadvantage of myocardial infarction in the canine left ventricle. Circ. Res. 1980, 47:728-741. 10.1161/01.RES.47.5.728.
43. Dang A.B.C., Guccione J.M., Zhang P., Wallace A.W., Gorman R.C., Gorman J.H., et al. Effect of ventricular size and patch stiffness in surgical anterior ventricular restoration: a finite element model study. Ann. Thorac. Surg. 2005, 79:185-193. 10.1016/j.athoracsur.2004.06.007.
44. Janz R.F., Waldron R.J. Predicted effect of chronic apical aneurysms on the passive stiffness of the human left ventricle. Circ. Res. 1978, 42:255-263. 10.1161/01.RES.42.2.255.
45. Clarke S.A., Ghanta R.K., Ailawadi G., Holmes J.W. Cardiac Restraint & Support Following Myocardial Infarction, in: Cardiovascular and Cardiac Therapeutic Devices 2014, 169-206. Springer-Verlag, Berlin Heidelberg. 10.1007/8415_2013_163.
46. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015, 131:e29-322. 10.1161/CIR.0000000000000152.
47. Braunwald E. Heart failure. JACC Heart Fail. 2013, 1:1-20. 10.1016/j.jchf.2012.10.002.
48. Chareonthaitawee P., Christian T.F., Hirose K., Gibbons R.J., Rumberger J.A. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J. Am. Coll. Cardiol. 1995, 25:567-573. 10.1016/0735-1097(94)00431-O.
49. McKay R.G., Pfeffer M.A., Pasternak R.C., Markis J.E., Come P.C., Nakao S., et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986, 74:693-702. 10.1161/01.CIR.74.4.693.
50. Pfeffer J.M., Pfeffer M.A., Fletcher P.J., Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol. 1991, 260:H1406-H1414.
51. Pfeffer M.A., Pfeffer J.M., Steinberg C., Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985, 72:406-412. 10.1161/01.RES.57.1.84.
52. Ryan L.P., Matsuzaki K., Noma M., Jackson B.M., Eperjesi T.J., Plappert T.J., et al. Dermal filler injection: a novel approach for limiting infarct expansion. Ann. Thorac. Surg. 2009, 87:148-155. 10.1016/j.athoracsur.2008.09.028.
53. Kelley S.T., Malekan R., Gorman J.H., Jackson B.M., Gorman R.C., Suzuki Y., et al. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation 1999, 99:135-142. 10.1161/01.CIR.99.1.135.
54. Liao S.-Y., Siu C.-W., Liu Y., Zhang Y., Chan W.-S., Wu E.X., et al. Attenuation of left ventricular adverse remodeling with epicardial patching after myocardial infarction. J. Card. Fail. 2010, 16:590-598. 10.1016/j.cardfail.2010.02.007.
55. Hutchins G.M., Bulkley B.H. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am. J. Cardiol. 1978, 41:1127-1132. 10.1016/0002-9149(78)90869-X.
56. Schuster E.H., Bulkley B.H. Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture. Circulation 1979, 60:1532-1538. 10.1161/01.CIR.60.7.1532.
57. Eaton L.W., Weiss J.L., Bulkley B.H., Garrison J.B., Weisfeldt M.L. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N. Engl. J. Med. 1979, 300:57-62. 10.1056/NEJM197901113000202.
58. Erlebacher J.A., Weiss J.L., Weisfeldt M.L., Bulkley B.H. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J. Am. Coll. Cardiol. 1984, 4:201-208. 10.1016/S0735-1097(84)80203-X.
59. Richardson W.J., Holmes J.W. Why is infarct expansion such an elusive therapeutic target?. J. Cardiovasc. Transl. Res. 2015, 8:421-430. 10.1007/s12265-015-9652-2.
60. McKinsey T. Fibroblasts as therapeutic targets for heart failure. J. Mol. Cell. Cardiol. 2016.
61. Roberts R., DeMello V., Sobel B.E. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 1976, 53:I204-I206.
62. Hammerman H., Kloner R.A., Hale S., Schoen F.J., Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation 1983, 68:446-452. 10.1161/01.CIR.68.2.446.
63. Mannisi J.A., Weisman H.F., Bush D.E., Dudeck P., Healy B. Steroid administration after myocardial infarction promotes early infarct expansion. A study in the rat. J. Clin. Invest. 1987, 79:1431-1439. 10.1172/JCI112971.
64. Hammerman H., Kloner R.A., Schoen F.J., Brown E.J., Hale S., Braunwald E. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation 1983, 67:1290-1295. 10.1161/01.CIR.67.6.1290.
65. Hammerman H., Schoen F.J., Braunwald E., Kloner R.A. Drug-induced expansion of infarct: morphologic and functional correlations. Circulation 1984, 69:611-617. 10.1161/01.CIR.69.3.611.
66. Brown E.J., Kloner R.A., Schoen F.J., Hammerman H., Hale S., Braunwald E. Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am. J. Cardiol. 1983, 51:877-883.
67. Ben-Mordechai T., Holbova R., Landa-Rouben N., Harel-Adar T., Feinberg M.S., Abd Elrahman I., et al. Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. J. Am. Coll. Cardiol. 2013, 62:1890-1901. 10.1016/j.jacc.2013.07.057.
68. Hartupee J., Mann D.L. Role of inflammatory cells in fibroblast activation. J. Mol. Cell. Cardiol. 2016, 93:143-148.
69. Turner N.A. Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). J. Mol. Cell. Cardiol. 2016, 10.1016/j.yjmcc.2015.11.002.
70. Papageorgiou A., Rienks M. Novel regulators of cardiac inflammation: matricellular proteins expand their repertoire. J. Mol. Cell. Cardiol. 2016, 91:172-178.
71. Rohde L.E., Ducharme A., Arroyo L.H., Aikawa M., Sukhova G.H., Lopez-Anaya A., et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999, 99:3063-3070.
72. Villarreal F.J., Griffin M., Omens J., Dillmann W., Nguyen J., Covell J. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation 2003, 108:1487-1492. 10.1161/01.CIR.0000089090.05757.34.
73. Yarbrough W.M., Mukherjee R., Brinsa T.A., Dowdy K.B., Scott A.A., Escobar G.P., et al. Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs. J. Thorac. Cardiovasc. Surg. 2003, 125:602-610. 10.1067/mtc.2003.197.
74. Ducharme A., Frantz S., Aikawa M., Rabkin E., Lindsey M., Rohde L.E., et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 2000, 106:55-62. 10.1172/JCI8768.
75. Koenig G.C., Rowe R.G., Day S.M., Sabeh F., Atkinson J.J., Cooke K.R., et al. MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction. Am. J. Pathol. 2012, 180:1863-1878. 10.1016/j.ajpath.2012.01.022.
76. Lindsey M.L., Yoshioka J., MacGillivray C., Muangman S., Gannon J., Verghese A., et al. Effect of a cleavage-resistant collagen mutation on left ventricular remodeling. Circ. Res. 2003, 93:238-245. 10.1161/01.RES.0000085580.45279.60.
77. Pilcher W., Richardson W.J., Holmes J.W. Modeling temporal dynamics of infarct collagen turnover. Biomed. Eng. Soc. 2014 Annu. Meet., San Antonio, TX 2014.
78. Cleutjens J.P., Verluyten M.J., Smiths J.F., Daemen M.J. Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 1995, 147:325-338.
79. Carlyle W.C., Jacobson A.W., Judd D.L., Tian B., Chu C., Hauer K.M., et al. Delayed reperfusion alters matrix metalloproteinase activity and fibronectin mRNA expression in the infarct zone of the ligated rat heart. J. Mol. Cell. Cardiol. 1997, 29:2451-2463. 10.1006/jmcc.1997.0482.
80. Cleutjens J.P., Kandala J.C., Guarda E., Guntaka R.V., Weber K.T. Regulation of collagen degradation in the rat myocardium after infarction. J. Mol. Cell. Cardiol. 1995, 27:1281-1292.
81. Peterson J.T., Li H., Dillon L., Bryant J.W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 2000, 46:307-315.
82. Tao Z.-Y., Cavasin M.A., Yang F., Liu Y.-H., Yang X.-P. Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci. 2004, 74:1561-1572. 10.1016/j.lfs.2003.09.042.
83. Lindsey M.L., Iyer R.P., Jung M., DeLeon-Pennell K., Ma Y. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling. J. Mol. Cell. Cardiol. 2016, 91:134-140.
84. Lindsey M.L., Gannon J., Aikawa M., Schoen F.J., Rabkin E., Lopresti-Morrow L., et al. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 2002, 105:753-758. 10.1161/hc0602.103674.
85. Yarbrough W.M., Mukherjee R., Escobar G.P., Mingoia J.T., Sample J.A., Hendrick J.W., et al. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling. Circulation 2003, 108:1753-1759. 10.1161/01.CIR.0000091087.78630.79.
86. Watanabe R., Ogawa M., Suzuki J., Hirata Y., Nagai R., Isobe M. A comparison between imidapril and ramipril on attenuation of ventricular remodeling after myocardial infarction. J. Cardiovasc. Pharmacol. 2012, 59:323-330. 10.1097/FJC.0b013e3182422c1a.
87. Palaniyappan A., Uwiera R.R.E., Idikio H., Jugdutt B.I. Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction. Mol. Cell. Biochem. 2009, 321:9-22. 10.1007/s11010-008-9905-3.
88. Zhou X., Yun J.-L., Han Z.-Q., Gao F., Li H., Jiang T.-M., et al. Postinfarction healing dynamics in the mechanically unloaded rat left ventricle. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H1863-H1874. 10.1152/ajpheart.00830.2010.
89. Fomovsky G.M., Macadangdang J.R., Ailawadi G., Holmes J.W. Model-based design of mechanical therapies for myocardial infarction. J. Cardiovasc. Transl. Res. 2011, 4:82-91. 10.1007/s12265-010-9241-3.
90. Fomovsky G.M., Clark S.A., Parker K.M., Ailawadi G., Holmes J.W. Anisotropic reinforcement of acute anteroapical infarcts improves pump function. Circ. Heart Fail. 2012, 5:515-522. 10.1161/CIRCHEARTFAILURE.111.965731.
91. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006, 114:2627-2635. 10.1161/CIRCULATIONAHA.106.657270.
92. Kerckhoffs R.C.P., McCulloch A.D., Omens J.H., Mulligan L.J. Effects of biventricular pacing and scar size in a computational model of the failing heart with left bundle branch block. Med. Image Anal. 2009, 13:362-369. 10.1016/j.media.2008.06.013.
93. Zeigler A.C., Richardson W.J., Holmes J.W., Saucerman J.J. Computational modeling of cardiac fibroblasts and fibrosis. J. Mol. Cell. Cardiol. 2016, 93:73-83.
94. White H.D., Chew D.P. Acute myocardial infarction. Lancet 2008, 372:570-584. 10.1016/S0140-6736(08)61237-4.
95. Gorman R.C., Jackson B.M., Burdick J.A., Gorman J.H. Infarct restraint to limit adverse ventricular remodeling. J. Cardiovasc. Transl. Res. 2011, 4:73-81. 10.1007/s12265-010-9244-0.
96. Laeremans H., Hackeng T.M., van Zandvoort M.A.M.J., Thijssen V.L.J.L., Janssen B.J.A., Ottenheijm H.C.J., et al. Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 2011, 124:1626-1635. 10.1161/CIRCULATIONAHA.110.976969.